Safety and Efficacy of Glucomannan for Weight Loss in Overweight and Moderately Obese Adults

Table 2

Effects of glucomannan on efficacy outcomes (𝑁=47).

Characteristic: mean	Glucomannan (𝑛=23)			Control (𝑛=24)
	Baseline	2 weeks	8 weeks	Baseline	2 weeks	8 weeks
Weight, kg	83.75	83.43	83.36	85.4	85.3	84.97
Weight loss, kg	—	−.32	−.40	—	−.11	−.43
BMI, kg/m^2	30.69	30.56	30.64	30.97	30.56	30.66
Waist circum., cm	95.62	94.80	94.42	97.55	96.71	97.30
Hip circum., cm	113.90	113.66	113.26	113.56	113.65	112.28
Fat mass, kg	32.93	33.09	33.31	31.91	32.21	31.91
Fat-free mass, kg	51.99	51.66	51.66	50.71	50.26	49.68
Hunger, mm	43.64	39.10	43.87	42.61	43.48	39.59
Fullness, mm	34.34	48.18	38.86	40.00	45.65	50.00
Cholesterol, mg/dL	207.00	200.06	194.50	204.60	203.13	207.33
HDL, mg/dL	47.81	45.75	48.25	54.40	52.80	52.60
LDL, mg/dL	134.00	128.94	128.12	129.47	127.47	128.73
Triglycerides, mg/dL	125.31	126.00	115.94	104.13	114.40	130.33
Glucose, mg/dL	87.38	82.79	88.06	87.93	89.33	91.00